Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) - Total Assets
Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) holds total assets worth CN¥2.43 Billion CNY (≈ $355.94 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 002864 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Total Assets Trend (2013–2025)
This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's total assets have evolved over time, based on quarterly financial data. Check how high is Shaanxi Panlong Pharmaceutical Group Lim's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Asset Composition Analysis
Current Asset Composition (December 2025)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's total assets of CN¥2.43 Billion consist of 77.6% current assets and 22.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 47.1% |
| Accounts Receivable | CN¥423.39 Million | 18.2% |
| Inventory | CN¥110.82 Million | 4.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥51.93 Million | 2.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 002864 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's current assets represent 77.6% of total assets in 2025, an increase from 64.5% in 2013.
- Cash Position: Cash and equivalents constituted 47.1% of total assets in 2025, up from 19.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 18.2% of total assets.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Total Assets
Key competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
SIMCERE PHARMAC. GRP LTD
F:S2P
|
Germany | €14.73 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥11.13 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.76 | 3.96 | 2.24 |
| Quick Ratio | 3.53 | 3.72 | 2.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.41 Billion | CN¥1.35 Billion | CN¥500.75 Million |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Advanced Valuation Insights
This section examines the relationship between Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.95 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | 1.9% |
| Total Assets | CN¥2.32 Billion |
| Market Capitalization | $409.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's assets grew by 1.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
The table below shows the annual total assets of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.32 Billion ≈ $339.90 Million |
+1.88% |
| 2024-12-31 | CN¥2.28 Billion ≈ $333.64 Million |
+7.29% |
| 2023-12-31 | CN¥2.13 Billion ≈ $310.96 Million |
+10.06% |
| 2022-12-31 | CN¥1.93 Billion ≈ $282.53 Million |
+45.15% |
| 2021-12-31 | CN¥1.33 Billion ≈ $194.65 Million |
+14.42% |
| 2020-12-31 | CN¥1.16 Billion ≈ $170.12 Million |
+25.16% |
| 2019-12-31 | CN¥928.88 Million ≈ $135.92 Million |
+13.58% |
| 2018-12-31 | CN¥817.84 Million ≈ $119.68 Million |
+8.62% |
| 2017-12-31 | CN¥752.93 Million ≈ $110.18 Million |
+49.24% |
| 2016-12-31 | CN¥504.50 Million ≈ $73.82 Million |
+16.42% |
| 2015-12-31 | CN¥433.33 Million ≈ $63.41 Million |
+7.99% |
| 2014-12-31 | CN¥401.26 Million ≈ $58.72 Million |
+17.19% |
| 2013-12-31 | CN¥342.39 Million ≈ $50.10 Million |
-- |
About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more